News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Complix NV to Present at Upcoming BioEquity Europe 2013


5/21/2013 7:08:31 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HASSELT, Belgium, May 21, 2013 /PRNewswire/ --

Complix, a biopharmaceutical company focused on the discovery and development of Alphabodies™, a unique class of protein therapeutics that are active against intracellular disease targets, announces that its CEO Dr Mark Vaeck will present at BioEquity Europe 2013 in Stockholm, Sweden (May 22nd-23rd). Details of the presentation are listed below.

Dr Vaeck will highlight Complix' recent progress in applying its revolutionary Alphabody™ platform to generate novel therapeutics with first-in-class potential.

Help employers find you! Check out all the jobs and post your resume.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES